Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations (CROs), pharmaceutical companies, healthcare institutions, and academic research centers worldwide.
The company's product portfolio includes remote clinical trial monitoring devices, wearable health data collection systems, patient engagement platforms, electronic clinical outcome assessment (eCOA) solutions, digital research tools, remote safety monitoring systems, and decentralized trial support technologies. These solutions are designed to facilitate real-time data collection, improve participant engagement, streamline study management, and enhance operational efficiency throughout the clinical research process.
The global telehealth market is no longer a peripheral service but a core pillar of modern medicine. With the rise of Decentralized Clinical Trials (DCTs), the demand for medical-grade OEM hardware that can reliably capture data outside the clinic has surged by over 40% annually.
Standardized solutions often fail to meet the rigorous protocols of phase III trials. Custom OEM services allow for the integration of specific sensors, secure firmware, and branded interfaces that enhance patient compliance and data integrity.
As an exporter, we prioritize cross-border data compliance. Our devices are designed with local encryption standards in mind, ensuring that data gathered in Europe, North America, or Asia adheres to GDPR and HIPAA requirements.
Traditional clinical trials suffer from a 30% dropout rate due to travel burdens. Our remote monitoring technologies allow patients to participate from home, increasing diversity in patient cohorts and accelerating the time-to-market for life-saving drugs by up to 20%.
Located in the heart of China's "Silicon Valley of Hardware," our facility leverages the world's most dense ecosystem of electronic component suppliers. This geographical advantage translates into:
Comprehensive quality control procedures are implemented across product design, manufacturing, testing, and inspection processes to ensure consistent performance and product reliability. This is vital for high-stakes environments like the banking data rooms or chemical plants mentioned in our diverse product portfolio.
By 2026, our telehealth platforms will feature edge-AI processing, capable of pre-screening EEG and X-ray data before it reaches the clinician, highlighting anomalies in real-time.
Transitioning from 4G LTE to 5G RedCap to support high-density sensor environments in smart hospitals and large-scale decentralized trials without latency issues.
Developing biodegradable sensors and rechargeable, long-life power modules to reduce the environmental footprint of remote patient monitoring devices.
Serving customers across North America, Europe, Asia-Pacific, the Middle East, Latin America, and Africa, we understand that "Telehealth" looks different in every region. Our localization services include:
For existing hardware platforms with minor firmware customizations, lead times range from 4-8 weeks. For full ground-up ODM developments, the timeline typically spans 6-12 months, including regulatory testing phases.
We implement end-to-end encryption (AES-256), secure boot protocols to prevent firmware tampering, and utilize hardware-based TEE (Trusted Execution Environments) to protect sensitive patient biometrics.
Yes. Our digital research tools and patient engagement platforms are designed with HL7 FHIR standards in mind, allowing for seamless data interoperability with major health record systems like Epic or Cerner.
Precision and scale. Dongguan offers a unique blend of high-precision CNC machining, advanced electronics assembly, and a logistics network that can ship to any global port within 48 hours of production completion.
Absolutely. Our core focus is providing the "hardware backbone" for DCTs—enabling investigators to collect high-fidelity data from patients' homes without compromising the scientific rigor of the study.
Trial Medical
